An investigational cancer drug that targets tumors caused by mutations in the KRAS gene will be evaluated in phase 2 clinical trials, following promising safety and efficacy results in preli... Read more
Scientists at Cold Spring Harbor Laboratory (CSHL) have identified 10 cancer drugs currently in clinical trials that do not work how clinicians thought they would. In identifying what went w... Read more
Researchers have engineered gold-based molecules that target cancer cells and leave healthy cells unharmed, in a critical step towards precision cancer drugs with fewer toxic side effects. P... Read more
Targeting nanoparticles rotate faster and move across larger areas Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tiss... Read more
A strain of the common cold virus has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer, a new study in the medical journal Clinical Cancer Re... Read more
‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway It’s a feat three decades in the making: Harvard Univer... Read more
Researchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic reticulum (ER) stress response that is freque... Read more
A new method to diagnose cancer cells inside lymph nodes could allow doctors to treat cancers before they spread around the body. The vast majority of cancer deaths occur due to the spread o... Read more
An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers. Hokkaido University researchers have en... Read more
An interdisciplinary team of three Virginia Tech faculty members affiliated with the Macromolecules Innovation Institute has created a drug delivery system that could radically expand cancer... Read more
